Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice

Science

Volumn 339, Issue 6123, 2013, Pages 1100-1102

  Giovanoli, Sandra ^a   Engler, Harald ^b   Engler, Andrea ^b   Richetto, Juliet ^c   Voget, Mareike ^d,e   Willi, Roman ^f   Winter, Christine ^e   Riva, Marco A ^c   Mortensen, Preben B ^g,h   Schedlowski, Manfred ^b   Meyer, Urs ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF MILAN   (Italy)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^f F HOFFMANN LA ROCHE LTD   (Switzerland)

^g AARHUS UNIVERSITY   (Denmark)

^h Aarhus   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; DOPAMINE; CYTOKINE; POLYINOSINIC POLYCYTIDYLIC ACID;

BRAIN; DISEASE PREVALENCE; IMMUNE SYSTEM; INFECTIVITY; NEUROLOGY; NUMERICAL MODEL; PATHOLOGY; RODENT;

BEHAVIORAL SCIENCE; CORTICOSTERONE RELEASE; ENVIRONMENTAL FACTOR; EXPERIMENTAL MODEL; HIPPOCAMPUS; IMMUNE RESPONSE; INFECTION; MAZE TEST; MENTAL DISEASE; NEUROCHEMISTRY; NEUROLOGIC DISEASE; NONHUMAN; POSTNATAL DEVELOPMENT; PRENATAL EXPOSURE; PREPUBERTY; PRIORITY JOURNAL; PROGENY; SHORT SURVEY; STRESS; ANIMAL; ARTICLE; C57BL MOUSE; DISEASE MODEL; FEMALE; HUMAN; IMMUNOLOGY; MOUSE; PHYSIOLOGICAL STRESS; PREGNANCY; PUBERTY; VIROLOGY;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MENTAL DISORDERS; MICE; MICE, INBRED C57BL; POLY I-C; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PUBERTY; STRESS, PHYSIOLOGICAL;

EID: 84874355139     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1228261     Document Type: Short Survey

References (24)

1. A. S. Brown, Prog. Neurobiol. 93, 23 (2011).
2. C. B. Pedersen, P. B. Mortensen, Arch. Gen. Psychiatry 58, 1039 (2001).
3. M. R. Herbert, Curr. Opin. Neurol. 23, 103 (2010).
4. K. J. Tsuchiya, M. Byrne, P. B. Mortensen, Bipolar Disord. 5, 231 (2003).
5. J. G. Green et al., Arch. Gen. Psychiatry 67, 113 (2010).
6. W. C. Holmes, G. B. Slap, JAMA 280, 1855 (1998).
7. A. S. Brown, P. H. Patterson, Schizophr. Bull. 37, 284 (2011).
8. F. Varese et al., Schizophr. Bull. 38, 661 (2012).
9. J. P. Selten, A. Frissen, G. Lensvelt-Mulders, V. A. Morgan, Schizophr. Bull. 36, 219 (2010).
10. S. A. Mednick, R. A. Machon, M. O. Huttunen, D. Bonett, Arch. Gen. Psychiatry 45, 189 (1988).
11. M. C. Clarke, A. Tanskanen, M. Huttunen, J. C. Whittaker, M. Cannon, Am. J. Psychiatry 166, 1025 (2009).
12. T. A. Bayer, P. Falkai, W. Maier, J. Psychiatr. Res. 33, 543 (1999).
13. T. M. Maynard, L. Sikich, J. A. Lieberman, A. S. LaMantia, Schizophr. Bull. 27, 457 (2001).
14. U. Meyer, J. Feldon, S. H. Fatemi, Neurosci. Biobehav. Rev. 33, 1061 (2009).
15. L. P. Spear, Dev. Psychopathol. 21, 87 (2009).
16. H. L. Fisher et al., Psychol. Med. 40, 1967 (2010).
17. T. Paus, M. Keshavan, J. N. Giedd, Nat. Rev. Neurosci. 9, 947 (2008).
18. E. Y. Hsiao, S. W. McBride, J. Chow, S. K. Mazmanian, P. H. Patterson, Proc. Natl. Acad. Sci. U.S.A. 109, 12776 (2012).
19. U. Meyer, J. Feldon, O. Dammann, Pediatr. Res. 69, 26R (2011).
20. M. G. Frank, M. V. Baratta, D. B. Sprunger, L. R. Watkins, S. F. Maier, Brain Behav. Immun. 21, 47 (2007).
21. T. B. Franklin, B. J. Saab, I. M. Mansuy, Neuron 75, 747 (2012).
22. R. M. Ransohoff, V. H. Perry, Annu. Rev. Immunol. 27, 119 (2009).
23. R. M. Ransohoff, A. E. Cardona, Nature 468, 253 (2010).
24. J. L. Bolton et al., FASEB J. 26, 4743 (2012).